Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
46.53
+0.27 (0.58%)
Aug 5, 2026, 2:32 PM EDT - Market open
Spruce Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
14
Market Cap
128.06M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 4.91M | -5.18M | -51.32% |
| Dec 31, 2023 | 10.09M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
SPRB News
- 2 days ago - Spruce Biosciences appoints Jessica Cohen Pfeffer as VP, clinical development - TheFly
- 2 days ago - Spruce Biosciences Appoints Jessica Cohen Pfeffer, M.D., as Vice President, Clinical Development - Business Wire
- 9 days ago - Spruce Biosciences appoints Quartel as Chief Medical Officer - TheFly
- 9 days ago - Spruce Biosciences Appoints Adrian Quartel, M.D., FFPM, as Chief Medical Officer - Business Wire
- 23 days ago - Spruce Biosciences initiated with a Buy at B. Riley - TheFly
- 27 days ago - Spruce Biosciences to Participate in the B. Riley Securities 2026 Mind, Muscle & Vision Healthcare Summit - Business Wire
- 5 weeks ago - Spruce Biosciences joins Russell 3000 Index - TheFly
- 5 weeks ago - Spruce Biosciences Joins the Russell 3000® Index - Business Wire